Stock DVYSR DEVYSER DIAGNOSTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

All News Devyser Diagnostics AB

Equities

DVYSR

SE0016588867

Market Closed - Nasdaq Stockholm
Other stock markets
 12:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
112 SEK +2.75% Intraday chart for Devyser Diagnostics AB +0.90% +42.49%
Jun. 17 Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products CI
Jun. 14 Devyser Launches Updated Y-Chromosomal Microdeletion Test CI

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Devyser announces expanded commercial agreement with Thermo Fisher Scientific for post-transplant monitoring NGS products
AQ
Devyser Diagnostics AB Announces Expanded Commercial Agreement with Thermo Fisher Scientific for Post-Transplant Monitoring NGS Products
CI
Devyser Launches Updated Y-Chromosomal Microdeletion Test
CI
Devyser Wins Up to SEK75 Million Tender for Diagnostic Systems in Italy
MT
Devyser Wins All-Time High Tender for Up to SEK 75 Million
CI
Devyser Wins Tender for Oncology NGS Solutions in Italy
CI
Devyser Wins Tender for Thalassemia in Italy
CI
Bulletin from the Annual General Meeting of Devyser Diagnostics AB (publ) held on 14 May 2024
AQ
Devyser Diagnostics AB Appoints Thomas Eklund as Member of the Board of Directors
CI
Devyser Diagnostics Q1 - The recognition of Devyser begins
AQ
Transcript : Devyser Diagnostics AB, Q1 2024 Earnings Call, May 08, 2024
Devyser Diagnostics AB publishes quarterly report for the period January to March 2024
AQ
Devyser Diagnostics AB Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Invitation to audiocast for Devyser’s Q1 report 2024
AQ
Devyser Receives IVDR Approval for Post-Transplant Monitoring Software
CI
Devyser partners with Hamilton to automate laboratory NGS workflows
AQ
Devyser Diagnostics AB Enters into Co-Marketing Agreement with Hamilton Bonaduz AG
CI
Devyser receives MDSAP certification for Brazil
AQ
Devyser Diagnostics AB Achieves Breakthrough in the US with Cystic Fibrosis NGS Test
CI
Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patient
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. DVYSR Stock
  4. News Devyser Diagnostics AB